We are grateful for the collaborative feedback from FDA on the Gemini program, which provides us a clear and expedient path forward for seeking approval of Gemini as a treatment for AKI,” said, James ...

The Food and Drug Administration has extended the review period for sparsentan in focal segmental glomerulosclerosis (FSGS).

We look at the Novo Nordisk A/S outlook for 2026: new CEO focus, oral Wegovy edge vs Eli Lilly, and double-digit growth ...

Medicare plans to cap costs for GLP-1 weight-loss drugs like Wegovy at about $50 a month under a new agreement set to launch ...

Known for their comedy chops in movies, podcasts, and TV shows, Justin Long and John Hodgman explain how Ozempic (semaglutide) stands apart from other GLP-1 medications in a new series of ...

Ibuprofen may be doing more than easing aches and pains—it could also help reduce the risk of some cancers. Studies have ...

Tim Andrews was among the world's first recipients of a genetically modified pig kidney a year ago. Now, he is the first in ...

Tim Andrews set a world record — living with a genetically modified pig kidney for 271 days. Now, he has a human kidney again ...

When Apellis Pharmaceuticals (APLS) secured FDA approval for EMPAVELI in C3 glomerulopathy and IC-MPGN last summer, the stock was trading near $28. Today it sits at $19.96, down 31% over the past year ...

The second man to receive a pig kidney transplant at Mass General Brigham now has a new human kidney. Tim Andrews, of New ...